# Karim Hakimzadeh

> Karim Hakimzadeh is a seed investor backing Biopharma and Biotechnology. See 1 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: Angel Investor
- Total investments: 1
- Last investment: Jan 2018
- Lead investor: 0%
- Last updated: Sep 2026

Karim Hakimzadeh is a seed investor focused on Biopharma and Biotechnology. Karim Hakimzadeh

## Contacts

5 contacts available for Karim Hakimzadeh: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/karim-hakimzadeh?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Juvenescence | Juvenescence Limited is a British Virgin Islands-based holding company that invests in human aging and longevity. Juvenescence has raised $111M to build an ecosystem and pipeline of assets targeting aging, age-related disease, and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development oftherapeutics that meaningfully extend human healthspan and eventually lifespan. A meaningful increase in lifespan in the already aging world will have profound implications on all sectors of society, and in particular healthcare, education, insurance, and leisure.The company creates and partners with new companies with longevity-related therapeutics, by in-licensing compounds from academia and industry, or forming joint ventures with the foremost longevity scientists and leading research institutions. Their work is based on a novel scientific understanding of the underlying biological causes of aging, to create evidence-based therapeutics that can treat diseases of aging.Juvenescence's goal is to extend both lifespan and healthspan, by developing therapeutics that slow aging and promote juvenescence. | $12.3M | Seed | Jan 08, 2018 |  |

1 of 1 investments shown.

## Co-investors
- [Foresite Capital](https://shizune.co/investors/profile/foresite-capital) — VC Fund, 2 deals together
- [Apeiron Investment Group](https://shizune.co/investors/profile/apeiron-investment-group) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Blockchain Founders Fund](https://shizune.co/investors/profile/blockchain-founders-fund) — VC Fund
- [Force Over Mass Capital](https://shizune.co/investors/profile/force-over-mass-capital) — VC Fund
- [NewBound Venture Capital](https://shizune.co/investors/profile/excelsior-financial-partners) — VC Fund

## Featured in investor lists
- [All Angel Investors in Isle of Man](https://shizune.co/investors/angel-investors-isle-of-man)

## FAQ

### What does Karim Hakimzadeh invest in?

Karim Hakimzadeh invests primarily in Biopharma, Biotechnology and Pharmaceutical startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Isle of Man. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Karim Hakimzadeh?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Karim Hakimzadeh last invest?

The most recent investment recorded for Karim Hakimzadeh closed in Jan 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co